Halsted WS. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June, 1889, to January 1894. Arch Surg. 1894;20:497–555.
Martini N. Mediastinal lymph node dissection for lung cancer. The memorial experience. Chest Surg Clin North Am. 1995;5:189–203.
Graham EA, Singer JJ. Successful removal of an entire lung. J Am Med Assoc. 1933;101:1371–4.
Archibald E. The technique of total unilateral pneumonectomy. Ann Surg. 1934;100:796–811.
Oschner A, Debakey M Symposium on cancer. Primary pulmonary malignancy. Treatment by total pneumonectomy. Analysis of 79 collected cases and presentation of 7 personal cases. Surg Gynecol Obstet. 1939;68:435–41.
Churchill ED, Sweet RH, Soutter L, Scannell JG. The surgical management of carcinoma of the lung. A study of the cases treated at the Massachusetts General Hospital from 1930 to 1950. J Thorac Surg. 1950;20:349–63.
Cahan WG, Watson WL, Pool JL. Radical pneumonectomy. J Thorac Surg. 1951;22:449–73.
Martini N, Flehinger BJ, Zaman MB, Beattie EJ Jr. Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases. Ann Surg. 1983;198:386–96.
Naruke T, Goya T, Tsuchiya R, Suemasu K. The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis. Ann Thorac Surg. 1988;46:603–10.
Tsang GMK, Watson DCT. The practice of cardiothoracic surgeons in the perioperative staging of non-small cell lung cancer. Thorax. 1992;47:3–5.
Goldstraw P. The practice of cardiothoracic surgeons in the perioperative staging of non-small cell lung cancer. Editorial. Thorax. 1992;47:1–2.
Little AG, Rusch VW, Bonner JA, Gaspar LE, Green MR, Webb WR, et al. Patterns of surgical care of lung cancer patients. Ann Thorac Surg. 2005;80:2051–6.
Keller SM. Complete mediastinal lymph node dissection—does it make a difference? Commentary. Lung Cancer. 2002;36:7–8.
Kondo T, Sagawa M, Tanita T, Sato M, Ono S, Matsumura Y, et al. Is complete systematic nodal dissection by thoracoscopic surgery possible? A prospective trial of video-assisted lobectomy for cancer of the right lung. J Thorac Cardiovasc Surg. 1998;116:651–2.
Sagawa M, Sato M, Sakurada A, Matsumura Y, Endo C, Handa M, et al. A prospective trial of systematic nodal dissection for lung cancer by video-assisted thoracic surgery: can it be perfect? Ann Thorac Surg. 2002;73:900–4.
Watanabe A, Koyanagi T, Obama T, Ohsawa H, Mawatari T, Takahashi N, et al. Assessment of node dissection for clinical stage 1 primary lung cancer by VATS. Eur J Cardiovasc Thorac Surg. 2005;27:745–52.
D’Amico TA, Niland J, Mamet R, Zornosa C, Dexter EU, Onaitis MW. Efficacy of mediastinal node dissection during lobectomy for lung cancer by thoracoscopy and thoracotomy. Ann Thorac Surg. 2011;92:226–32.
Oda M, Watanabe Y, Shimizu J, Murakami S, Ohta Y, Sekido et al. Extent of mediastinal node metastasis in clinical stage 1 non-small-cell lung cancer: the role of systematic nodal dissection. Lung Cancer. 1998;22:23–30.
Okada M, Tsubota N, Yoshimura M, Miyamoto Y. Proposal for reasonable mediastinal lymphadenectomy in bronchogenic carcinomas: role of subcarinal nodes in selective dissection. J Thorac Cardiovasc Surg. 1998;116:949–53.
Asamura H, Nakayama H, Kondo H, Tsuchiya R, Naruke T, et al. Lobe-specific extent of systematic lymph node dissection for non-small cell lung carcinomas according to a retrospective study of metastases and prognosis. J Thorac Cardiovasc Surg. 1999;117:1102–11.
Okada M, Sakamoto T, Yuki T, Mimura T, Miyoshi K, Tsubota N. Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer. Ann Thorac Surg. 2006;81:1028–33.
Ishiguro F, Matsuo K, Fukui T, Mori S, Hatooka S, Mitsudomi T. Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non-small cell lung cancer: a large-scale retrospective cohort study applying a propensity score. J Thorac Cardiovasc Surg. 2010;139:1001–6.
Hata E, Hayakawa K, Miyamoto H, Hayashida R. Rationale for extended lymphadenectomy for lung cancer. Theor Surg. 1990;5:19–25.
Watanabe Y, Ichihashi T, Iwa T. Median sternotomy as an approach for pulmonary surgery. Thorac Cardiovasc Surg. 1988;36:227–31.
Watanabe Y, Shimizu J, Oda M, Hayashi Y, Tatsuzawa Y, Watanabe S, et al. Improved survival in left non-small-cell N2 lung cancer after more extensive operative procedure. Thorac Cardiovasc Surg. 1991;39:89–94.
Nakahara K, Fujii Y, Matsumura A, Minami M, Okumura M, Matsuda H. Role of systematic mediastinal dissection in N2 non-small cell lung cancer patients. Ann Thorac Surg. 1993;56:331–6.
Gaer JAR, Goldstraw P. Intraoperative assessment of nodal staging at thoracotomy for carcinoma of the bronchus. Eur J Cardiothorac Surg. 1990;4:207–10.
Sioris T, Järvenpää R, Kuukasjärvi P, Helin H, Saarelainen S, Tarkka M. Comparison of computed tomography and systematic lymph node dissection in determining TNM and stage in non-small cell lung cancer. Eur J Cardiothorac Surg. 2003;23:403–8.
Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med. 2003;348:2500–7.
Lardinois D, Suter H, Hakki H, Rousson V, Betticher D, Ris HB. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer. Ann Thorac Surg. 2005;80:268–75.
Darling GE, Maziak DE, Inculet RI, Gulenchyn KY, Driedger AA, Ung YC. Positron emission tomography-computed tomography compared with invasive mediastinal stating in non-small cell lung cancer: results of mediastinal staging in the early lung position emission tomography trial. J Thorac Oncol. 2011;6:1367–72.
Lv YL, Yuan DM, Wang K, Miao XH, Qian Q, Wei SZ. Diagnostic performance of integrated position emission tomography/computed tomography for mediastinal lymph node staging in non-small cell lung cancer. A bivariate systematic review and meta-analysis. J Thorac Oncol. 2011;6:1350–8.
D’Cunha J, Herndon JE 2nd, Herzan DL, Patterson GA, Kohman LJ, Harpole DH, et al. Poor correspondence between clinical and pathologic staging in stage I non-small cell lung cancer: results from CALGB 9761, a prospective trial. Lung Cancer. 2005;48:241–6.
Coughlin M, Deslauriers J, Beaulieu M, Fournier B, Piraux M, Rouleau J, et al. Role of mediastinoscopy in pretreatment staging of patients with primary lung cancer. Ann Thorac Surg. 1985;40:556–60.
Funatsu T, Matsubara Y, Ikeda S, Hatakenaka R, Hanawa T, Ishida H, et al. Preoperative mediastinoscopic assessment of N factor and the need for mediastinal lymph node dissection in T1 lung cancer. J Thorac Cardiovasc Surg. 1994;108:321–8.
Whitson BA, Groth SS, Maddaus MA. Surgical assessment and intraoperative management of mediastinal lymph nodes in non-small cell lung cancer. Ann Thorac Surg. 2007;84:1059–65.
Asamura H, Nakayama H, Kondo H, Tsuchiya R, Shimosato Y, Naruke T. Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: are these carcinomas candidates for video-assisted lobectomy? J Thorac Cardiovasc Surg. 1996;111:1125–34.
Takizawa T, Terashima M, Koike T, Akamatsu H, Kurita Y, Yokoyama A. Mediastinal lymph node metastasis in patients with clinical stage 1 peripheral non-small-cell lung cancer. J Thorac Cardiovasc Surg. 1997;113:248–52.
Ishida T, Yano T, Maeda K, Kaneko S, Tateishi M, Sugimachi K. Strategy for lymphadenectomy in lung cancer three centimeters or less in diameter. Ann Thorac Surg. 1990;50:708–13.
Naruke T, Tsuchiya R, Kondo H, Nakayama H, Asamura H. Lymph node sampling in lung cancer: how should it be done? Eur J Cardiothorac Surg. 1999;16(Suppl 1):S17–24.
Tateishi M, Fukuyama Y, Hamatake M, Kohdono S, Ishida T, Sugimachi K. Skip mediastinal lymph node metastasis in non-small cell lung cancer. J Surg Oncol. 1994;57:139–42.
Izbicki JR, Thetter O, Habekost M, Karg O, Passlick B, Kubuschok B, et al. Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer: a randomized controlled trial. Br J Surg. 1994;81:229–35.
Allen MS, Darling GE, Pechet TTV, Mitchell JD, Herndon JE 2nd, Landreneau RJ. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg. 2006;81:1013–20.
Bollen ECM, van Duin CJ, Theunissen PHMH, vt Hof-Grootenboer BE, Blijham GH. Mediastinal lymph node dissection in resected lung cancer: morbidity and accuracy of staging. Ann Thorac Surg. 1993;55:961–6.
Lewis RJ. Is radical lymphadenectomy a valid oncologic procedure? Editorial. Eur J Cardio-Thorac Surg. 1999;16(Suppl 1):S11–2.
Reid SE, Kaufman MW, Murthy S, Scanlon EF. Perioperative stimulation of residual cancer cells promotes local and distant recurrence of breast cancer: collective review. J Am Coll Surg. 1997;185:290–306.
Ginsberg RJ. Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas. Editorial. J Thorac Cardio Vasc Surg. 1996;111:1123–4.
Ginsberg RJ, Rubinstein LV, for the Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Ann Thorac Surg. 1995;60:615–23.
Thomas P, Rubinstein L. Lung Cancer Study Group. Cancer recurrence after resection: T1N0 non-small cell lung cancer. Ann Thorac Surg. 1990;49:242–7.
Izbicki JR, Passlick B, Karg O, Bloechle C, Pantel K, Knoefel WT, et al. Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer. Ann Thorac Surg. 1995;59:209–14.
Graham ANJ, Chan KJM, Pastorino U, Goldstraw P. Systematic nodal dissection in the intra thoracic staging of patients with non-small cell lung cancer. J Thorac Cardio Vasc Surg. 1999;117:246–51.
Keller SM, Adak S, Wagner H, Johnson DH. Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Ann Thorac Surg. 2000;70:358–66.
Doddoli C, Aragon A, Barlesi F, Chetaille B, Robitail S, Giudicelli R, et al. Does the extent of lymph node dissection Influence outcome in patients with stage 1 non-small cell lung cancer? Eur J Cardio-Thorac Surg. 2005;27:680–5.
Massard G, Ducrocq Y, Kochetkova EA, Porhanov VA, Riquet M. Sampling or node dissection for intraoperative staging of lung cancer: a multicentric cross-sectional study. Eur J Cardio-Thorac Surg. 2006;30:164–7.
Varlotto JM, Recht A, Nikolov M, Flickinger JC, Decamp MM. Extent of lymphadenectomy and outcome for patients with stage 1 nonsmall cell lung cancer. Cancer. 2009;115:851–8.
Ma K, Chang D, He B, Gong M, Tian F, Hu X, et al. Radical systematic mediastinal lymphadenectomy versus mediastinal lymph node sampling in patients with clinical stage 1A and pathological stage T1 non-small cell lung cancer. J Cancer Res Clin Oncol. 2008;134:1289–95.
Takizawa H, Kondo K, Matsuoka H, Uyama K, Toba H, Kenzaki K, et al. Effect of mediastinal nodes sampling in patients with clinical stage 1 non-small cell lung cancer. J Med Investig. 2008;55:37–43.
Okasaka T, Usami N, Taniguchi T, Kawaguchi K, Okagawa T, Suzuki H, et al. Can non-performance of radical systematic mediastinal lymphadenectomy be justified in elderly lung cancer patients? An evaluation using propensity-based survival analysis. Eur J Cardio-Thorac Surg. 2010;38:27–33.
Izbicki JR, Passlick B, Pantel K, Pichlmeier U, Hosch SB, Karg O, et al. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer. Results of a prospective randomized trial. Ann Surg. 1998;227:138–44.
Sugi K, Nawata K, Fujita N, Ueda K, Tanaka T, Matsuoka T, et al. Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2 cm in diameter. World J Surg. 1998;22:290–5.
Wu YL, Huang ZF, Wang SY, Yang XN, Ou W. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer. 2002;36:1–6.
Darling GE, Allen MS, Decker PA, Ballman K, Malthaner RA, Inculet RI, et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 trial. J Thorac Cardio Vasc Surg. 2011;141:662–70.
Tagaki H, Matsui M. Alice in Wonderland of mediastinal lymph nodes. Letter to the Editor. J Thorac Cardiovasc Surg. 2011;142:477–9.
Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg. 1998;227:645–53.
Krag D, Weaver D, Ashikaga T, Harlow SP, O’Connell M. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med. 1998;339:941–6.
Liptay MJ. Commentary on sentinel lymph node identification with technetium-99 m tin colloid in non-small cell lung cancer. Editorial. J Thorac Cardiovasc Surg. 2002;124:428–30.
Schmidt FE, Woltering EA, Webb WR, Garcia OM, Cohen JE, Rozans MH. Sentinel node assessment in patients with carcinoma of the lung. Ann Thorac Surg. 2002;74:870–5.
Yoshimasu T, Miyoshi S, Oura S, Hirai I, Kokawa Y, Okamura Y. Limited mediastinal lymph node dissection for non-small cell lung cancer according to intraoperative histologic examinations. J Thorac Cardiovasc Surg. 2005;130:433–7.
Liptay MJ, Masters GA, Winchester DJ, Edelman BL, Garrido BJ, Hirschtritt TR, et al. Intraoperative radio isotope sentinel lymph node mapping in non-small cell lung cancer. Ann Thorac Surg. 2000;70:384–90.
Nomori H, Horio H, Naruke T, Orikasa H, Yamazaki K, Suemasu K. Use of technecium-99 m tin colloid for sentinel lymph node identification in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2002;124:486–92.
Ueda K, Suga K, Kaneda Y, Li TS, Ueda K, Hamano K. Preoperative imaging of the lung sentinel lymphatic basin with computed tomographic lymphography: a preliminary study. Ann Thorac Surg. 2004;77:1033–8.
Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, et al. Prognostic factors in colorectal cancer. College of American Pathologists consensus statement 1999. Arch Pathol Lab Med. 2000;124:979–94.
Wu YC, Lin CFJ, Hsu WH, Huang BS, Huang MH, Wang LS. Long-term results of pathological stage 1 non-small cell lung cancer: validation of using the number of totally removed lymph nodes as a staging control. Eur J Cardio-Thorac Surg. 2003;24:994–1001.
Gajra A, Newman N, Gamble GP, Kohman LJ, Graziano SL. Effect of number of lymph nodes sampled on outcome in patients with stage 1 non-small-cell lung cancer. J Clin Oncol. 2003;21:1029–34.
Ludwig MS, Goodman M, Miller DL, Johnstone PAS. Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer. Chest. 2005;128:1545–50.
Saji H, Tsuboi M, Yoshida K, Kato Y, Nomura M, Matsubayashi J, et al. Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer. J Thorac Oncol. 2011;6:1865–71.
Chen ZL, Perez S, Holmes EC, Wang HJ, Coulson WF, Wen DR, et al. Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small cell lung carcinoma. J Natl Cancer Inst. 1993;85:493–8.
Passlik B, Kubuschock B, Sienel W, Thetter O, Pantel K, Izbicki JR. Mediastinal lymphadenectomy in non-small cell lung cancer: effectiveness in patients with or without nodal micrometastasis: results of a preliminary study. Eur J Cardio-Thorac Surg. 2002;21:520–6.
Passlik B, Izbicki JR, Kubuschok B, Thetter O, Pantel K. Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis. Ann Thorac Surg. 1996;61:177–83.
Maruyama R, Sugio K, Mitsudomi T, Saitoh G, Ishida T, Sugimachi K. Relationship between early recurrence and micrometastases in the lymph nodes of patients with stage 1 non-small-cell lung cancer. J Thorac Cardio Vasc Surg. 1997;114:535–43.